| Name | Title | Contact Details |
|---|
Real-time PCR testing for everyone Watch the video Amplifying human potential through real-time PCR It all starts with a single sample. Add chemistry, heat, and light to make the fragments of a single virus visible by amplification up to a billion fold...
CCA Industries, Inc. (CCA) is engaged in the health and beauty aids business, selling numerous products in several health and beauty aids and cosmeceutical categories.
Unlike traditional approaches that only address symptoms, Cardionomic addresses the conditions root cause of reduced contractility. The therapy uses neuromodulation to benignly increase contractility, thus improving cardiac output therefore increasing renal flow and end organ perfusion. Benignly increasing contractility decreases negative hormonal signaling, and improves in-hospital morbidity/mortality. This breakthrough therapy is also expected to increase pharmacological tolerance at discharge, which will reduce costly readmission and extend life. Spun off from Denali Medical II, a New Enterprise Associates (NEA) backed incubator, Cardionomic is funded by NEA, Greatbatch Medical and Cleveland Clinic Foundation.
Relmada Therapeutics (OTCQB: RLMD) is a clinical-stage, publicly traded specialty pharmaceutical company developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of chronic pain. Relmada has a diversified portfolio of four lead products at various stages of development including d-Methadone (REL-1017) its N-methyl-D-aspartate (NMDA) receptor antagonist for neuropathic pain; topical mepivacaine (REL-1021), its orphan drug designated topical formulation of the local anesthetic mepivacaine; oral buprenorphine (REL-1028) its oral dosage form of the opioid analgesic buprenorphine; and LevoCap ER (REL-1015), its abuse resistant, sustained release dosage form of the opioid analgesic levorphanol. Relmada`s product development efforts are guided by the internationally recognized scientific expertise of our research team. Relmada`s approach is expected to reduce clinical development risks and costs while potentially delivering valuable products in areas of high unmet medical needs.
HealthEast Care System is a community-focused, nonprofit healthcare system that provides a full spectrum of HealthEast Care System is a community-focused, nonprofit healthcare system that provides a full spectrum of family health services. Hospitals include St. Joseph`s Hospital, St. John`s Hospital, Woodwinds Health Campus and Bethesda Rehabilitation Hospital. Other services include hospitals, physician clinics, senior care centers, rehabilitation facilities, hospice, home care, outpatient surgery centers, and a variety of other health facilities and programs. HealthEast has approximately 7,500 employees and has more than 1,300 physicians on staff. Locally owned and operated, HealthEast is the largest health care provider in the Twin Cities` East Metro area.